News and Comments

THREE SMALL BIOTECH FIRMS IN THE SPOTLIGHT

  Wednesday, July 31, 2013

Three biotechnology firms with market caps below $1billion have been recently put in the spotlight; SYNTA (SNTA) with a market cap of 535.54 million, ARRAY (ARRY) with a market cap of 774.22 million, and VANDA (VNDA) with a market cap of 320.45 million. More...


Recent Postings


Archive


Tags

Genentech ARCA (ABIO) Jazz Pharmaceuticals (JAZZ) Merck (MRK) VANDA (VNDA) galapagos (GLPG) Ionis (IONS) Intermune (ITMN) OSI (OSIP) NEKTAR (NKTR)) Cytokinetics (CYTK) REGULUS (RGLS) Regeneron (REGN) Inovio (INO) Biogen Idec (BIIB) Anacor (ANAC) Biocryst (BCRX) Auspex (ASPX) ADVENTRIX (ANX) Sanofi (SNY) JUNO (JUNO) ISIS (ISIS) Theravance (THRX) Exelixis (EXEL) Aimmune Therapeutics (AIMT) Rapamune Velcade (bortezomib) NANTKWEST (NK) Sanofi (SNA) BIOMARIN (BMRN) CompuGen (CGEN) Vitae Pharmaceuticals (VTAE) Roche (RHHBY) Ariad (ARIA) Sarepta (SRPT) Endometrial Cancer Trastuzumab-DM1 Amgen (AMGN) Benlysta (belimumab) Agenus (AGEN) Revlimid (lenolidamide) Multiple Myeloma Dynavax (DVAX) Dendreon (DNDN) Prolor Biotech (PBTH) Onyx (ONXX) Bristol-Myers Squibb (BMY) Alnylam (ALNY) ABBVIE (ABBV) Idenix (IDIX) Alder Biopharmaceuticals (ALDR) Illumina (ILMN) Human Genome Sciences (HGSI) ZALTRAP™ HALOZYME (HALO) Array Pharmaceuticals (ARRY) Gilead (GILD) KITE (KITE) SYNTA (SNTA) C4 Therapeutics GlaxoSmithKline (GSK) Ridaforolimus Anadys (ANDS) ImmunoGen (IMGN) Incyte (INCY) Tysabri Sanofi-Aventis (SAN) Ziofpharm (ZIOP) ACADIA (ACAD) Abbott Laboratories (ABT) Human Longevity (HLI) Sequenom (SQNM) Roche (ROCHE) Elan (ELN) Xoma (XOMA) Micromet (MITI) Herceptin Pluristem (PSTI) Zerenex Valeant Pharmaceuticals International (VRX) IDERA (IDRA) Vertex (VRTX) SUNESIS PHARMACEUTICALS (SNSS) Intercept (ICPT) Intrexon (XON) KERYX (KERX) Seattle Genetics (SGEN) Prosensa (RNA) Mirati Therapeutics (MRTX) Agenus (AGEN TOKAI (TKAOI) AERIE PHARMACEUTICALS Galena (GALE) Sangamo (SGMO) GUARDIAN HEALTH SERES THERAPEUTICS (MCRB) Theravance Bio Pharma (TBPH) Telaprevir